nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—CYP1A2—chronic obstructive pulmonary disease	0.684	1	CbGaD
Tenofovir—NME1—respiratory system—chronic obstructive pulmonary disease	0.00523	0.0984	CbGeAlD
Tenofovir—AK4—respiratory system—chronic obstructive pulmonary disease	0.00504	0.0948	CbGeAlD
Tenofovir—NME2—respiratory system—chronic obstructive pulmonary disease	0.00493	0.0926	CbGeAlD
Tenofovir—NME1—connective tissue—chronic obstructive pulmonary disease	0.0046	0.0866	CbGeAlD
Tenofovir—AK4—bronchus—chronic obstructive pulmonary disease	0.00415	0.078	CbGeAlD
Tenofovir—NME2—bronchus—chronic obstructive pulmonary disease	0.00406	0.0762	CbGeAlD
Tenofovir—AK4—trachea—chronic obstructive pulmonary disease	0.00373	0.07	CbGeAlD
Tenofovir—AK2—lung—chronic obstructive pulmonary disease	0.00362	0.068	CbGeAlD
Tenofovir—NME1—lung—chronic obstructive pulmonary disease	0.00278	0.0522	CbGeAlD
Tenofovir—AK4—lung—chronic obstructive pulmonary disease	0.00268	0.0503	CbGeAlD
Tenofovir—NME2—lung—chronic obstructive pulmonary disease	0.00262	0.0492	CbGeAlD
Tenofovir—NME1—Arf6 downstream pathway—PLAUR—chronic obstructive pulmonary disease	0.00243	0.089	CbGpPWpGaD
Tenofovir—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00197	0.037	CbGeAlD
Tenofovir—ABCC10—trachea—chronic obstructive pulmonary disease	0.00177	0.0332	CbGeAlD
Tenofovir—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00163	0.0307	CbGeAlD
Tenofovir—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.0014	0.0512	CbGpPWpGaD
Tenofovir—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00135	0.0253	CbGeAlD
Tenofovir—ABCC10—lung—chronic obstructive pulmonary disease	0.00127	0.0239	CbGeAlD
Tenofovir—ABCC4—lung—chronic obstructive pulmonary disease	0.00105	0.0198	CbGeAlD
Tenofovir—NME1—Arf6 trafficking events—ADRB2—chronic obstructive pulmonary disease	0.000927	0.034	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000874	0.00372	CcSEcCtD
Tenofovir—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000874	0.00372	CcSEcCtD
Tenofovir—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.00372	CcSEcCtD
Tenofovir—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000867	0.00369	CcSEcCtD
Tenofovir—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.00363	CcSEcCtD
Tenofovir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000851	0.00362	CcSEcCtD
Tenofovir—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00085	0.00361	CcSEcCtD
Tenofovir—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000837	0.00356	CcSEcCtD
Tenofovir—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000837	0.00356	CcSEcCtD
Tenofovir—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00356	CcSEcCtD
Tenofovir—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00355	CcSEcCtD
Tenofovir—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000833	0.00354	CcSEcCtD
Tenofovir—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000833	0.00354	CcSEcCtD
Tenofovir—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000831	0.00353	CcSEcCtD
Tenofovir—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.00353	CcSEcCtD
Tenofovir—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00083	0.00353	CcSEcCtD
Tenofovir—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000822	0.0035	CcSEcCtD
Tenofovir—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00082	0.00349	CcSEcCtD
Tenofovir—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00082	0.00349	CcSEcCtD
Tenofovir—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000816	0.00347	CcSEcCtD
Tenofovir—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000814	0.00346	CcSEcCtD
Tenofovir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000812	0.00345	CcSEcCtD
Tenofovir—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00336	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000788	0.0289	CbGpPWpGaD
Tenofovir—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00334	CcSEcCtD
Tenofovir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000784	0.00334	CcSEcCtD
Tenofovir—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000784	0.00334	CcSEcCtD
Tenofovir—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000778	0.00331	CcSEcCtD
Tenofovir—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000778	0.00331	CcSEcCtD
Tenofovir—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000778	0.00331	CcSEcCtD
Tenofovir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000776	0.0033	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000773	0.00329	CcSEcCtD
Tenofovir—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000765	0.00326	CcSEcCtD
Tenofovir—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000765	0.00326	CcSEcCtD
Tenofovir—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00325	CcSEcCtD
Tenofovir—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00325	CcSEcCtD
Tenofovir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00321	CcSEcCtD
Tenofovir—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000754	0.00321	CcSEcCtD
Tenofovir—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00075	0.00319	CcSEcCtD
Tenofovir—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000748	0.00318	CcSEcCtD
Tenofovir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000748	0.00318	CcSEcCtD
Tenofovir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000747	0.00318	CcSEcCtD
Tenofovir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000743	0.00316	CcSEcCtD
Tenofovir—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00316	CcSEcCtD
Tenofovir—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00316	CcSEcCtD
Tenofovir—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00314	CcSEcCtD
Tenofovir—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00314	CcSEcCtD
Tenofovir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000732	0.00311	CcSEcCtD
Tenofovir—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00309	CcSEcCtD
Tenofovir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000725	0.00308	CcSEcCtD
Tenofovir—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00307	CcSEcCtD
Tenofovir—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00307	CcSEcCtD
Tenofovir—CYP1A2—lung—chronic obstructive pulmonary disease	0.000716	0.0135	CbGeAlD
Tenofovir—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000716	0.00304	CcSEcCtD
Tenofovir—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00303	CcSEcCtD
Tenofovir—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00303	CcSEcCtD
Tenofovir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000705	0.003	CcSEcCtD
Tenofovir—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00298	CcSEcCtD
Tenofovir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00296	CcSEcCtD
Tenofovir—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000696	0.00296	CcSEcCtD
Tenofovir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000688	0.00292	CcSEcCtD
Tenofovir—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00292	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00068	0.00289	CcSEcCtD
Tenofovir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000675	0.00287	CcSEcCtD
Tenofovir—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00287	CcSEcCtD
Tenofovir—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00287	CcSEcCtD
Tenofovir—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.00287	CcSEcCtD
Tenofovir—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00066	0.00281	CcSEcCtD
Tenofovir—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000657	0.00279	CcSEcCtD
Tenofovir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000647	0.00275	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00274	CcSEcCtD
Tenofovir—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00271	CcSEcCtD
Tenofovir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00267	CcSEcCtD
Tenofovir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00266	CcSEcCtD
Tenofovir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00266	CcSEcCtD
Tenofovir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000625	0.00266	CcSEcCtD
Tenofovir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000625	0.00266	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00265	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00265	CcSEcCtD
Tenofovir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00262	CcSEcCtD
Tenofovir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00262	CcSEcCtD
Tenofovir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00261	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000611	0.0026	CcSEcCtD
Tenofovir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00061	0.00259	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000595	0.0218	CbGpPWpGaD
Tenofovir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00252	CcSEcCtD
Tenofovir—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00252	CcSEcCtD
Tenofovir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00252	CcSEcCtD
Tenofovir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00251	CcSEcCtD
Tenofovir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00251	CcSEcCtD
Tenofovir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00251	CcSEcCtD
Tenofovir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00251	CcSEcCtD
Tenofovir—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000585	0.00249	CcSEcCtD
Tenofovir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00249	CcSEcCtD
Tenofovir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00249	CcSEcCtD
Tenofovir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000583	0.00248	CcSEcCtD
Tenofovir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00246	CcSEcCtD
Tenofovir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000573	0.00244	CcSEcCtD
Tenofovir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.00239	CcSEcCtD
Tenofovir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00238	CcSEcCtD
Tenofovir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00237	CcSEcCtD
Tenofovir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00235	CcSEcCtD
Tenofovir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.00234	CcSEcCtD
Tenofovir—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00234	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000549	0.00233	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.00233	CcSEcCtD
Tenofovir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00232	CcSEcCtD
Tenofovir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00232	CcSEcCtD
Tenofovir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.0023	CcSEcCtD
Tenofovir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000541	0.0023	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000537	0.00228	CcSEcCtD
Tenofovir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00228	CcSEcCtD
Tenofovir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00228	CcSEcCtD
Tenofovir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00227	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000531	0.0194	CbGpPWpGaD
Tenofovir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00225	CcSEcCtD
Tenofovir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00225	CcSEcCtD
Tenofovir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.00224	CcSEcCtD
Tenofovir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00222	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00221	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00221	CcSEcCtD
Tenofovir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00221	CcSEcCtD
Tenofovir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00221	CcSEcCtD
Tenofovir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00221	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.0022	CcSEcCtD
Tenofovir—Pain—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00219	CcSEcCtD
Tenofovir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00219	CcSEcCtD
Tenofovir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00219	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00217	CcSEcCtD
Tenofovir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00216	CcSEcCtD
Tenofovir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00216	CcSEcCtD
Tenofovir—Pain—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00214	CcSEcCtD
Tenofovir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00214	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00213	CcSEcCtD
Tenofovir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00213	CcSEcCtD
Tenofovir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000499	0.00212	CcSEcCtD
Tenofovir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00212	CcSEcCtD
Tenofovir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00211	CcSEcCtD
Tenofovir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.0021	CcSEcCtD
Tenofovir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.0021	CcSEcCtD
Tenofovir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00209	CcSEcCtD
Tenofovir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00209	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00209	CcSEcCtD
Tenofovir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00208	CcSEcCtD
Tenofovir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00207	CcSEcCtD
Tenofovir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00205	CcSEcCtD
Tenofovir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00202	CcSEcCtD
Tenofovir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00202	CcSEcCtD
Tenofovir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00202	CcSEcCtD
Tenofovir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00202	CcSEcCtD
Tenofovir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00202	CcSEcCtD
Tenofovir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.002	CcSEcCtD
Tenofovir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.002	CcSEcCtD
Tenofovir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.002	CcSEcCtD
Tenofovir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000467	0.00199	CcSEcCtD
Tenofovir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00198	CcSEcCtD
Tenofovir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00198	CcSEcCtD
Tenofovir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00198	CcSEcCtD
Tenofovir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00191	CcSEcCtD
Tenofovir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00191	CcSEcCtD
Tenofovir—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000445	0.0163	CbGpPWpGaD
Tenofovir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00189	CcSEcCtD
Tenofovir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00189	CcSEcCtD
Tenofovir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.00188	CcSEcCtD
Tenofovir—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000439	0.00187	CcSEcCtD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000437	0.016	CbGpPWpGaD
Tenofovir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00185	CcSEcCtD
Tenofovir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00184	CcSEcCtD
Tenofovir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00184	CcSEcCtD
Tenofovir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00181	CcSEcCtD
Tenofovir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00181	CcSEcCtD
Tenofovir—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00181	CcSEcCtD
Tenofovir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000423	0.0018	CcSEcCtD
Tenofovir—AK2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000421	0.0154	CbGpPWpGaD
Tenofovir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00178	CcSEcCtD
Tenofovir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00177	CcSEcCtD
Tenofovir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000412	0.00175	CcSEcCtD
Tenofovir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.00175	CcSEcCtD
Tenofovir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00174	CcSEcCtD
Tenofovir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00173	CcSEcCtD
Tenofovir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00172	CcSEcCtD
Tenofovir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00171	CcSEcCtD
Tenofovir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00169	CcSEcCtD
Tenofovir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00169	CcSEcCtD
Tenofovir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00166	CcSEcCtD
Tenofovir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00165	CcSEcCtD
Tenofovir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00163	CcSEcCtD
Tenofovir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00163	CcSEcCtD
Tenofovir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00161	CcSEcCtD
Tenofovir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00161	CcSEcCtD
Tenofovir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00161	CcSEcCtD
Tenofovir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00161	CcSEcCtD
Tenofovir—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.0139	CbGpPWpGaD
Tenofovir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.0016	CcSEcCtD
Tenofovir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000377	0.0016	CcSEcCtD
Tenofovir—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000377	0.0016	CcSEcCtD
Tenofovir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.0016	CcSEcCtD
Tenofovir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000376	0.0016	CcSEcCtD
Tenofovir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00159	CcSEcCtD
Tenofovir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00158	CcSEcCtD
Tenofovir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00158	CcSEcCtD
Tenofovir—Depression—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00158	CcSEcCtD
Tenofovir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000369	0.00157	CcSEcCtD
Tenofovir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00155	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00155	CcSEcCtD
Tenofovir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00154	CcSEcCtD
Tenofovir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Tenofovir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Tenofovir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Tenofovir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00152	CcSEcCtD
Tenofovir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00151	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000353	0.0129	CbGpPWpGaD
Tenofovir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00149	CcSEcCtD
Tenofovir—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000345	0.0126	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00034	0.0124	CbGpPWpGaD
Tenofovir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00144	CcSEcCtD
Tenofovir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00139	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000324	0.0119	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—chronic obstructive pulmonary disease	0.000322	0.0118	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00134	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00128	CcSEcCtD
Tenofovir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00125	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000295	0.0108	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000295	0.0108	CbGpPWpGaD
Tenofovir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00124	CcSEcCtD
Tenofovir—NME2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000292	0.0107	CbGpPWpGaD
Tenofovir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00123	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000281	0.0103	CbGpPWpGaD
Tenofovir—AK2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000279	0.0102	CbGpPWpGaD
Tenofovir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00119	CcSEcCtD
Tenofovir—AK2—Metabolism—GC—chronic obstructive pulmonary disease	0.000271	0.00994	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000267	0.00979	CbGpPWpGaD
Tenofovir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00113	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000262	0.00961	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00942	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000252	0.00924	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000248	0.0091	CbGpPWpGaD
Tenofovir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00105	CcSEcCtD
Tenofovir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00105	CcSEcCtD
Tenofovir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00105	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00104	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00102	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000239	0.00876	CbGpPWpGaD
Tenofovir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000988	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000979	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000974	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000226	0.00828	CbGpPWpGaD
Tenofovir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00096	CcSEcCtD
Tenofovir—NME1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000221	0.0081	CbGpPWpGaD
Tenofovir—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00798	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000217	0.00794	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000918	CcSEcCtD
Tenofovir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000917	CcSEcCtD
Tenofovir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000911	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00021	0.00769	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000209	0.00766	CbGpPWpGaD
Tenofovir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000887	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000876	CcSEcCtD
Tenofovir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000874	CcSEcCtD
Tenofovir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000873	CcSEcCtD
Tenofovir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000869	CcSEcCtD
Tenofovir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000869	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000202	0.00738	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00726	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000824	CcSEcCtD
Tenofovir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000824	CcSEcCtD
Tenofovir—NME2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000193	0.00708	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000193	0.00708	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000192	0.00704	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000189	0.00691	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GC—chronic obstructive pulmonary disease	0.000188	0.00689	CbGpPWpGaD
Tenofovir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000797	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000797	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000183	0.0067	CbGpPWpGaD
Tenofovir—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.00667	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000182	0.00667	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000181	0.00664	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000179	0.00654	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000177	0.00649	CbGpPWpGaD
Tenofovir—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00642	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000175	0.0064	CbGpPWpGaD
Tenofovir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000742	CcSEcCtD
Tenofovir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000723	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000168	0.00616	CbGpPWpGaD
Tenofovir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000713	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000163	0.00597	CbGpPWpGaD
Tenofovir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000689	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000162	0.00593	CbGpPWpGaD
Tenofovir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000666	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000155	0.00567	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000154	0.00562	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000153	0.00561	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000151	0.00552	CbGpPWpGaD
Tenofovir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000641	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000151	0.00552	CbGpPWpGaD
Tenofovir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000635	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000635	CcSEcCtD
Tenofovir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000631	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000148	0.00543	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000146	0.00537	CbGpPWpGaD
Tenofovir—NME1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000146	0.00537	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000144	0.00529	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GC—chronic obstructive pulmonary disease	0.000143	0.00522	CbGpPWpGaD
Tenofovir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000599	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000136	0.005	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00496	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000135	0.00495	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00493	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000134	0.0049	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000133	0.00487	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000132	0.00485	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000131	0.00479	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000129	0.00474	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000129	0.00473	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000124	0.00453	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00451	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.00451	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000123	0.0045	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000118	0.00434	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000117	0.00428	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000114	0.00416	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000112	0.0041	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000109	0.00398	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000107	0.0039	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000106	0.0039	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00382	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000103	0.00376	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000103	0.00376	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000102	0.00372	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000101	0.00372	CbGpPWpGaD
Tenofovir—AK2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000101	0.00371	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.44e-05	0.00346	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00343	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00343	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00343	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.27e-05	0.00339	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.22e-05	0.00338	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.11e-05	0.00334	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.95e-05	0.00328	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.95e-05	0.00328	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	8.89e-05	0.00326	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.75e-05	0.00321	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.54e-05	0.00313	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	8.47e-05	0.0031	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	8.16e-05	0.00299	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.79e-05	0.00285	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	7.77e-05	0.00285	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	7.77e-05	0.00285	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.7e-05	0.00282	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.56e-05	0.00277	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.46e-05	0.00273	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.12e-05	0.00261	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.02e-05	0.00257	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.02e-05	0.00257	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.01e-05	0.00257	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	6.73e-05	0.00247	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.54e-05	0.0024	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.47e-05	0.00237	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00234	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.2e-05	0.00227	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.00225	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALB—chronic obstructive pulmonary disease	6.08e-05	0.00223	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	6.04e-05	0.00221	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00215	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.82e-05	0.00213	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	5.73e-05	0.0021	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	5.72e-05	0.0021	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	5.45e-05	0.002	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.4e-05	0.00198	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.39e-05	0.00198	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.33e-05	0.00195	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.32e-05	0.00195	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.24e-05	0.00192	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.18e-05	0.0019	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.04e-05	0.00185	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.96e-05	0.00182	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.7e-05	0.00172	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.44e-05	0.00163	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.38e-05	0.00161	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.37e-05	0.0016	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.25e-05	0.00156	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.25e-05	0.00156	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALB—chronic obstructive pulmonary disease	4.22e-05	0.00154	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.03e-05	0.00148	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.02e-05	0.00147	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.94e-05	0.00144	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.00144	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.00144	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.89e-05	0.00143	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.82e-05	0.0014	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.79e-05	0.00139	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.76e-05	0.00138	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.76e-05	0.00138	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.00137	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.7e-05	0.00136	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.00135	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.62e-05	0.00133	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.59e-05	0.00131	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.51e-05	0.00129	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.00126	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.00124	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.00119	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.00118	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-05	0.00117	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-05	0.00112	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.96e-05	0.00108	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2.95e-05	0.00108	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.82e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.66e-05	0.000976	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.62e-05	0.00096	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.55e-05	0.000936	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000814	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000789	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.03e-05	0.000745	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000684	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.000684	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000636	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.69e-05	0.000619	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.57e-05	0.000575	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.54e-05	0.000563	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000458	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.22e-06	0.000338	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.12e-06	0.000334	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.5e-06	0.000311	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.32e-06	0.000305	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.39e-06	0.000234	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.3e-06	0.000231	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.87e-06	0.000215	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.57e-06	0.000204	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.79e-06	0.000139	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.62e-06	0.000133	CbGpPWpGaD
